Fig. 1
From: Phase I clinical trial results of aceneuramic acid for GNE myopathy in Japan
Timing of administration of test drugs, blood sampling, and meals in Trial-1 and Trial-2. a. Single administration and three-times-per-day administration for Trial-1. b. Three times per day for 5-day administration for Trial-1. c. Single administration and three-times-per-day administration for Trial-2. d. Three times per day for 7-day administration for Trial-2. Triangle indicates the timing of administration. Arrows indicate the timing of blood collection. Stars indicate meals. Since aceneuramic acid also exists intravitally, we measured it during the day before the start of administration as well